Clinique Sainte-Elisabeth; Oncologie
Namur 5000
0 studies enrolling now · 2 studies all time
What they study most
Breast Cancer, Triple Negative Breast Cancer
Studies at this site
- A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
- A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer — Completed